Generate Biomedicines
GENB
#5747
Rank
HK$9.65 B
Marketcap
HK$74.78
Share price
-8.00%
Change (1 day)
N/A
Change (1 year)

EPS for Generate Biomedicines (GENB)

EPS in 2026 (TTM): -HK$21.43

According to Generate Biomedicines's latest financial reports the company's current EPS (TTM) is -HK$21.45. In 2025 the company made an earnings per share (EPS) of -HK$17.09 a decrease over its 2024 EPS that were of -HK$16.38.

EPS history for Generate Biomedicines from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$21.4325.4%
2025-HK$17.094.33%
2024-HK$16.38